A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Janux Therapeutics Inc’s current trading price is -29.12% away from its 52-week high, while its distance from the 52-week low is 496.92%. The stock’s price range for this time frame has been between $7.79 and $65.60. The trading volume of the company’s shares in the Healthcare reached around 0.79 million for the day, which was evidently higher than the average daily volume of 0.6 million over the last three months.
The stock market performance of Janux Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $65.60 on 05/03/24, while the lowest price during the same time frame was $7.79, recorded on 02/05/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Janux Therapeutics Inc (JANX) has experienced a quarterly rise of 1.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.44B and boasts a workforce of 64 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.23, with a change in price of +7.20. Similarly, Janux Therapeutics Inc recorded 589,608 in trading volume during the last 100 days, posting a change of +18.32%.
How JANX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for JANX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
JANX Stock Stochastic Average
Janux Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 25.52%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 4.54%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.28% and 12.99%, respectively.
JANX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 333.36% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 8.09%. Over the past 30 days, the price of JANX has leaped by -10.14%. And in the last five days, it has fallen by -9.00%.
